Pharmexcil, USP Discuss Collaboration on Biosimilar Accessibility, Building Resilient Supply Chain
This discussion between Pharmaceuticals Export Promotion Council of India (Pharmexcil) and United States Pharmacopoeia (USP) happened during the United States Pharmacopoeial (USP) Convention-2025 held recently, which brought together representatives from across the health and science ecosystem to launch the 2025–2030 cycle.
Pharmexcil, USP Collaboration | 30/06/2025 | By Darshana | 140
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy